CGON
Cg Oncology Inc.

499
Mkt Cap
$4.74B
Volume
1.06M
52W High
$60.00
52W Low
$14.80
PE Ratio
-29.64
CGON Fundamentals
Price
$58.80
Prev Close
$56.11
Open
$55.79
50D MA
$49.69
Beta
1.60
Avg. Volume
1.51M
EPS (Annual)
-$2.08
P/B
6.69
Rev/Employee
$28,450.70
$2,474.50
Loading...
Loading...
News
all
press releases
Vanguard Group Inc. Has $264.93 Million Stock Position in CG Oncology, Inc. $CGON
Vanguard Group Inc. boosted its position in shares of CG Oncology, Inc. (NASDAQ:CGON - Free Report) by 11.4% in the 3rd quarter, according to its most recent filing with the Securities & Exchange...
MarketBeat·14h ago
News Placeholder
More News
News Placeholder
CG Oncology, Inc. (NASDAQ:CGON) Given Consensus Recommendation of "Moderate Buy" by Brokerages
CG Oncology, Inc. (NASDAQ:CGON - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the fourteen ratings firms that are presently covering the stock, Marketbeat.com...
MarketBeat·2d ago
News Placeholder
What Analysts Are Saying About CG Oncology Stock
read more...
Benzinga·2d ago
News Placeholder
HC Wainwright Issues Positive Forecast for CG Oncology (NASDAQ:CGON) Stock Price
HC Wainwright upped their target price on shares of CG Oncology from $75.00 to $80.00 and gave the company a "buy" rating in a report on Friday...
MarketBeat·2d ago
News Placeholder
CG Oncology (NASDAQ:CGON) Trading Up 5.6% Following Strong Earnings
CG Oncology (NASDAQ:CGON) Trading 5.6% Higher After Strong Earnings...
MarketBeat·2d ago
News Placeholder
CG Oncology (NASDAQ:CGON) Hits New 12-Month High - Here's Why
CG Oncology (NASDAQ:CGON) Hits New 12-Month High - Still a Buy...
MarketBeat·9d ago
News Placeholder
CenterBook Partners LP Has $15.92 Million Stake in CG Oncology, Inc. $CGON
CenterBook Partners LP increased its stake in shares of CG Oncology, Inc. (NASDAQ:CGON - Free Report) by 52.0% during the 3rd quarter, according to the company in its most recent disclosure with the...
MarketBeat·12d ago
News Placeholder
Candriam S.C.A. Grows Position in CG Oncology, Inc. $CGON
Candriam S.C.A. boosted its position in CG Oncology, Inc. (NASDAQ:CGON - Free Report) by 35.9% in the third quarter, according to the company in its most recent disclosure with the Securities and...
MarketBeat·21d ago
News Placeholder
CG Oncology, Inc. (NASDAQ:CGON) Sees Large Decline in Short Interest
CG Oncology, Inc. (NASDAQ:CGON - Get Free Report) saw a large drop in short interest in January. As of January 15th, there was short interest totaling 9,387,150 shares, a drop of 27.3% from the...
MarketBeat·30d ago
News Placeholder
CG Oncology (NASDAQ:CGON) Sets New 52-Week High - Should You Buy?
CG Oncology (NASDAQ:CGON) Sets New 12-Month High - Should You Buy...
MarketBeat·1mo ago
<
1
2
...
>

Latest CGON News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.